Cytori Expands European Approval for Celution(R) System for New Indications, Including Intractable Cryptoglandular Fistulae; Investigator-Sponsored Fistula Repair Study Initiated in Japan
09 août 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Aug 9, 2012) - Cytori Therapeutics (NASDAQ: CYTX) has expanded the Celution® System CE Mark in Europe to include several new indications, including cryptoglandular...
Cytori Provides Business Update and Reports Second Quarter and First Half 2012 Results
08 août 2012 16h05 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Aug 8, 2012) - During the second quarter and first half of 2012, Cytori Therapeutics (NASDAQ: CYTX) made key advancements in its cardiac cell therapy pipeline, achieved...
Cytori to Webcast Second Quarter Financial Results on August 8
26 juil. 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jul 26, 2012) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Wednesday, August 8, 2012...
Cytori Obtains Celution(R) Approval in Russia; To Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies
30 mai 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 30, 2012) - Cytori Therapeutics (NASDAQ: CYTX) has obtained approval to sell the Celution® 800 System in Russia for various medical uses. These clinical uses...
Cytori to Present at the Jefferies 2012 Global Healthcare Conference on June 5
23 mai 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 23, 2012) - Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5,...
Cytori Provides Business Update; Reports First Quarter Results
09 mai 2012 16h05 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 9, 2012) - During the first quarter of 2012, Cytori Therapeutics (NASDAQ: CYTX) advanced its cardiac cell therapy product pipeline, grew the commercial business,...
Cytori to Webcast First Quarter Financial Results May 9
27 avr. 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Apr 27, 2012) - Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its first quarter financial results and business update on Wednesday, May 9, 2012 at...
Cytori Breast Reconstruction Cell Therapy Trial Results Published
19 mars 2012 06h00 HE
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND and SAN DIEGO, CA--(Marketwire - Mar 19, 2012) - Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal...
FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850
16 mars 2012 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Mar 16, 2012) - Cytori (NASDAQ: CYTX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Puregraft® 850 System for body...
Cytori Provides Strategic Outlook, Near Term Objectives and Reports Year-End 2011 Results
08 mars 2012 16h05 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Mar 8, 2012) - In 2011, Cytori Therapeutics (NASDAQ: CYTX) achieved important objectives towards validating Celution® technology in multiple large market...